Viemed Healthcare (VMD) CEO granted RSUs and phantom units, sells shares

Rhea-AI Filing Summary

Viemed Healthcare CEO Hoyt Casey reported multiple equity transactions. On January 17, 2026, previously granted awards vested, resulting in the acquisition of 40,068 common shares and 10,017 common shares tied to phantom share vesting. To cover tax obligations and settle cash awards, 12,118 shares were withheld by the company and 10,017 shares were disposed of at $7.33 per share.

Following these transactions, Casey directly held 288,550 common shares and also reported indirect beneficial ownership of 1,984,943 common shares held by Elizabeth Rose Homes LLC. On January 19, 2026, he received new grants of 172,155 restricted stock units and 43,039 phantom share units, each representing the value of one common share and scheduled to vest in three equal annual installments beginning one year after the grant dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoyt Casey

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/17/2026		M		40,068	A	(1)	300,668	D
Common Shares	01/17/2026		F		12,118(2)	D	$7.33(3)	288,550	D
Common Shares	01/17/2026		M		10,017	A	(4)	298,567	D
Common Shares	01/17/2026		D		10,017	D	$7.33(3)	288,550	D
Common Shares								1,984,943	I	by Elizabeth Rose Homes LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/17/2026		M			40,068	(5)	01/17/2026	Common Shares	40,068	$0	0	D
Phantom Share Units	(4)	01/17/2026		M			10,017	(6)	01/17/2026	Common Shares	10,017	(4)	0	D
Restricted Stock Units	(1)	01/19/2026		A		172,155		(7)	01/19/2029	Common Shares	172,155	$0	172,155	D
Phantom Share Units	(8)	01/19/2026		A		43,039		(9)	01/19/2029	Common Shares	43,039	$0	43,039	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

3. Per share value is based on the market closing price of the common shares for January 16, 2026.

4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

5. Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.

6. Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

7. Restricted Stock Units (RSUs) granted to reporting person on January 19, 2026, which vest in three equal annual installments beginning on the first anniversary of the grant date.

8. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.

9. Represents an award granted on January 19, 2026 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	01/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Viemed Healthcare (VMD) CEO Hoyt Casey report on this Form 4?

CEO Hoyt Casey, also a director of Viemed Healthcare, Inc., reported vesting of restricted stock units and phantom share units, related share issuances, tax-withholding share disposals, and new grants of equity-based awards.

How many Viemed Healthcare common shares does Hoyt Casey hold after the reported transactions?

After the reported transactions, Hoyt Casey directly held 288,550 common shares and reported indirect beneficial ownership of 1,984,943 common shares held by Elizabeth Rose Homes LLC.

What new equity awards did Viemed Healthcare grant to its CEO on January 19, 2026?

On January 19, 2026, Hoyt Casey received 172,155 restricted stock units and 43,039 phantom share units. The RSUs and phantom units each correspond to one common share in value and are scheduled to vest in three equal annual installments beginning on the first anniversary of the grant date.

What transactions occurred on January 17, 2026 involving Viemed Healthcare shares?

On January 17, 2026, 40,068 restricted stock units and 10,017 phantom share units vested, leading to acquisitions of the same number of common shares. To satisfy tax obligations and settle cash awards, 12,118 shares were withheld by the issuer and 10,017 shares were disposed of at $7.33 per share, based on the January 16, 2026 closing price.

How do Viemed Healthcare phantom share units work for the CEO?

Each phantom share unit is the economic equivalent of one Viemed Healthcare common share and represents a right to receive the cash value of one common share, determined based on the share price on the vesting date. When phantom shares vest and are settled, they are reported as dispositions of phantom shares and related acquisitions and dispositions of the underlying common shares.

Over what period do Hoyt Casey's Viemed RSUs and phantom share awards vest?

The awards granted on January 17, 2023 and January 19, 2026 vest in three equal annual installments, beginning on the first anniversary of each respective grant date, as described in the footnotes.